THE DEAL, AT A GLANCE
From the announcementEpicrispr Biotechnologies
01Who is involvedBacked by damageFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedEpicrispr Biotechnologies raised $90M Series C, announced 2026-08-11From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersEpicrispr Biotechnologies' $90M Series C is an above-median Healthcare & Life Sciences financing within an active trailing-30-day funding tape, positioning the round as…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Epicrispr Biotechnologies · Financing Record
Explore source-linked visual explanations for Epicrispr Biotechnologies. Unsupported claims are withheld while source review continues.
Record 10039 · Recorded date: 2026-08-11
Explore company records →